AbbVie and Genmab's latest win brings Epkinly closer to label expansion

June 30, 2026 12:49 PM EDT PharmaFDA+ Ab­b­Vie and Gen­mab's lat­est win brings Ep­kin­ly clos­er to la­bel ex­pan­sion Nicole DeFeudis Senior Reporter Ab­b­Vie and Gen­mab’s bis­pe­cif­ic an­ti­body Ep­kin­ly suc­ceed­ed in com­bi­na­tion with a wide­ly used can­cer drug, bring­ing it one step clos­er to a po­ten­tial la­bel ex­pan­sion … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER